Nov 15, 2018
Patients Launch New Study to Shed Light on EGFR-Positive Lung Cancers
Aug 28, 2018
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 13, 2018
Jul 12, 2018
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 26, 2018
May 23, 2018
Patient Derived Xenograft/PDx Models Market Worth 167.6 Million USD by 2022
May 17, 2018
Cancer Surgeon Fueled by a Passion to Do More Launches SpeciCare to Store Live Tumor Tissue for Personalized Use in Cancer Care
Mar 07, 2018
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 15, 2018
Feb 26, 2018
Champions Oncology to Participate at the 30th Annual ROTH Conference
Sep 26, 2017
Champions Oncology announces $2 million award from the National Cancer Institute (NCI) to develop and evaluate prostate cancer PDX models
Sep 18, 2017
Champions Oncology announces publication highlighting clinical correlation between patient-derived xenograft (PDX) model responses and patient responses to oncology therapies
Sep 14, 2017
Patient Derived Xenograft/PDX Models Market Worth 167.6 Million USD by 2022
Sep 07, 2017
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 14, 2017
Aug 21, 2017
Champions Oncology Announces Strategic Collaboration with AstraZeneca to Develop Unique Cohorts of Patient-Derived Xenograft (PDX) Models
Aug 18, 2017
Champions Oncology Announces Research Collaboration with The Addario Lung Cancer Medical Institute to Develop Unique Cohort of Patient-Derived Xenograft (PDX) Models